WaneboH.J., PaceR., HargettS., KatzD., SandoJ.Production and response to interleukin-2 in peripheral blood lymphocytes of cancer patients.Cancer1986; 57: 656–62.
2.
Van RoennJ., HarisJ.E., BraunD.P.Suppressor cell function in solid tumor cancer patients.J Clin Oncol1987; 5: 150–9.
3.
TanciniG., BarniS., RescaldaniR., FiorelliG., VivianiS., LissoniP.Analysis of T helper and suppressor lymphocyte subsets in relation to the clinical stage of solid neoplasms.Oncology1990; 47: 381–4.
4.
RubinL.A., KurmanC.C., FritzM.E.Soluble interleukin-2 receptors are released by activated lymphocytes in vitro.J Immunol1985; 135: 3172–77.
LissoniP., BarniS., RovelliF.The biological significance of soluble interleukin-2 receptors in solid tumors.Eur J Cancer1990; 26: 33–6.
7.
ReddyM.M., GriecoH.Elevated soluble interleukin-2 receptor levels in serum of human immunodeficiency virus infected populations.AIDS Res Human Retroviruses1988; 4: 115–20.
8.
ReddyM.M., LangeM., GriecoM.H.Elevated soluble CD8 levels in sera of human immunodeficiency virus-infected populations.J Clin Microbiol1989; 27: 257–60.
9.
ReddyM.M., VodianM., GriecoM.H.Elevated levels of CD4 antigen in sera of human immunodeficiency virus-infected populations.J Clin Microbiol1990; 28: 1744–6.
10.
LotzeM.T., CusterM.C., SharrowS.O., RubinL.A., NelsonD.L., RosenbergS.A.In vivo administration off purified human interleukin-2 to patients with cancer: development of interleukin-2 receptor positive cells and circulating soluble interleukin-2 receptors following interleukin-2 administration.Cancer Res1987; 47: 2188–95.
11.
MarinoP., CugnoM., PreatoniA.Increased levels of soluble interleukin-2 receptors in serum of patients with lung cancer.Br J Cancer1990; 61: 434–5.
12.
LissoniP., TisiE., BrivioF.Increase in soluble interleukin-2 receptor and neopterin serum levels during immunotherapy of cancer with interleukin-2.Eur J Cancer1991; 27: 1014–6.
